Search Results 5931-5940 of 17108 for mesenteric fat and ibd

1. AB-2100, An Integrated Circuit T (ICT) Cell Therapy In Patients With Recurrent Clear-cell Renal Cell Carcinoma (CcRCC) - Mayo Clinic

   About this study. This is a multi-center, open-label phase 1/2 trial evaluating the safety and efficacy of AB-2100 cell product. The study may enroll ...

2. Innovative Trial for Understanding the Impact of Targeted Therapies in NF2 - Mayo Clinic

   The purpose of this study is to test multiple experimental therapies simultaneously in patients with neurofibromatosis type 2 (NF2) with associated progressive ...

3. Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors - Mayo Clinic

   The purpose of this first in human study in patients with deleted Methylthioadenosine phosphorylase (MTAP) advanced or metastatic solid tumors is to detertamine ...

4. A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma - Mayo Clinic

   About this study. The primary purposes of this study are to identify experimental therapies that improve OS for GBM patients in the Screening stage (Stage ...

5. A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma - Mayo Clinic

   About this study. The purpose of the dose escalation part of the study is to characterize the safety and tolerability of ALN-BCAT as monotherapy and in ...

6. A Study to Evaluate the Effectiveness and Safety of an Amikacin Liposome Inhalation Suspension-based Regimen in Adults with Nontuberculous Mycobacterial Lung Infection - Mayo Clinic

   The purpose of this study is to evaluate the effectiveness of ALIS + azithromycin (AZI) + ethambutol (ETH) compared to the empty liposome control (ELC) + AZI + ...

7. Onyx™ Liquid Embolic IDE Clinical Study - Mayo Clinic

   The purpose of this study is to evaluate the safety and effectiveness of Onyx™ LES in the treatment of subjects with active arterial bleeding in the peripheral ...

8. A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer (MOUNTAINEER-03) - Mayo Clinic

   The purpose of this study is to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive ...

9. Open-Label Extension Study of Setmelanotide - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

10. Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants with Permanent Ileostomy

    About this study. The purpose of this study is to develop a Patient Reported Outcome (PRO) and Endoscopic Index (EI) for patients with Crohn's Disease (CD) ...